Nouveaux agents et nouvelles classes thérapeutiques (Ph I-Ph II)
- Author
- HEBRAUD, B1
[1] Service d'hématologie clinique, hôpital Purpan, Toulouse, France - Issue title
- Compte-rendu sur le myélome multiple d'après le 54e congrès de l'ASH American Society of Hematology, 8-11 décembre 2012, Atlanta
- Author (monograph)
- LELEU, Xavier (Author of introductory parts)1
[1] CHU de Lille, France - Source
Correspondances en onco-hématologie. 2013, Vol 8, Num 1, pp 11-15, 5 p ; SUP2 ; ref : 4 ref
- ISSN
- 1954-4820
- Scientific domain
- Medical oncology
- Publisher
- DaTeBe, Courbevoie
- Publication country
- France
- Document type
- Article
- Language
- French
- Keyword (fr)
- Anticancéreux Carfilzomib Chimiothérapie Homme Immunomodulateur Inhibiteur du protéasome Myélome Nouveauté Pomalidomide Traitement Hémopathie lymphoïde B Cancer Hémopathie maligne Immunoglobulinopathie Immunopathologie Syndrome lymphoprolifératif
- Keyword (en)
- Antineoplastic agent Carfilzomib Chemotherapy Human Immunomodulator Proteasome inhibitor Myeloma Novelty Pomalidomide Treatment B cell neoplasm Cancer Malignant hemopathy Immunoglobulinopathy Immunopathology Lymphoproliferative syndrome
- Keyword (es)
- Anticanceroso Carfilzomib Quimioterapia Hombre Inmunomodulador Inhibidor proteasome Mieloma Novedad Pomalidomida Tratamiento Cáncer Hemopatía maligna Inmunoglobulinopatía Inmunopatología Linfoproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D02 Immunoglobulinopathies
- Discipline
- Immunopathology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27278636
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:65:\"Nouveaux agents et nouvelles classes th\u00e9rapeutiques (Ph I-Ph II)\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Correspondances en onco-h\u00e9matologie\";s:9:\"\u0000*\u0000stitle\";s:0:\"\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:1:\"8\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"11\";s:8:\"\u0000*\u0000epage\";s:2:\"15\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1954-4820\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HEBRAUD\";s:10:\"\u0000*\u0000aufirst\";s:1:\"B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP2\";s:9:\"\u0000*\u0000btitle\";s:132:\"Compte-rendu sur le my\u00e9lome multiple d'apr\u00e8s le 54e congr\u00e8s de l'ASH American Society of Hematology, 8-11 d\u00e9cembre 2012, Atlanta\";s:8:\"\u0000*\u0000title\";s:65:\"Nouveaux agents et nouvelles classes th\u00e9rapeutiques (Ph I-Ph II)\";s:8:\"\u0000*\u0000place\";s:10:\"Courbevoie\";s:6:\"\u0000*\u0000pub\";s:6:\"DaTeBe\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:65:\"Nouveaux agents et nouvelles classes th\u00e9rapeutiques (Ph I-Ph II)\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Correspondances en onco-h\u00e9matologie\";s:9:\"\u0000*\u0000stitle\";s:0:\"\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:1:\"8\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"11\";s:8:\"\u0000*\u0000epage\";s:2:\"15\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1954-4820\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HEBRAUD\";s:10:\"\u0000*\u0000aufirst\";s:1:\"B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP2\";s:9:\"\u0000*\u0000btitle\";s:132:\"Compte-rendu sur le my\u00e9lome multiple d'apr\u00e8s le 54e congr\u00e8s de l'ASH American Society of Hematology, 8-11 d\u00e9cembre 2012, Atlanta\";s:8:\"\u0000*\u0000title\";s:65:\"Nouveaux agents et nouvelles classes th\u00e9rapeutiques (Ph I-Ph II)\";s:8:\"\u0000*\u0000place\";s:10:\"Courbevoie\";s:6:\"\u0000*\u0000pub\";s:6:\"DaTeBe\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:65:\"Nouveaux agents et nouvelles classes th\u00e9rapeutiques (Ph I-Ph II)\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Correspondances en onco-h\u00e9matologie\";s:9:\"\u0000*\u0000stitle\";s:0:\"\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:1:\"8\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"11\";s:8:\"\u0000*\u0000epage\";s:2:\"15\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1954-4820\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HEBRAUD\";s:10:\"\u0000*\u0000aufirst\";s:1:\"B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP2\";s:9:\"\u0000*\u0000btitle\";s:132:\"Compte-rendu sur le my\u00e9lome multiple d'apr\u00e8s le 54e congr\u00e8s de l'ASH American Society of Hematology, 8-11 d\u00e9cembre 2012, Atlanta\";s:8:\"\u0000*\u0000title\";s:65:\"Nouveaux agents et nouvelles classes th\u00e9rapeutiques (Ph I-Ph II)\";s:8:\"\u0000*\u0000place\";s:10:\"Courbevoie\";s:6:\"\u0000*\u0000pub\";s:6:\"DaTeBe\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:65:\"Nouveaux agents et nouvelles classes th\u00e9rapeutiques (Ph I-Ph II)\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Correspondances en onco-h\u00e9matologie\";s:9:\"\u0000*\u0000stitle\";s:0:\"\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:1:\"8\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"11\";s:8:\"\u0000*\u0000epage\";s:2:\"15\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1954-4820\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HEBRAUD\";s:10:\"\u0000*\u0000aufirst\";s:1:\"B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP2\";s:9:\"\u0000*\u0000btitle\";s:132:\"Compte-rendu sur le my\u00e9lome multiple d'apr\u00e8s le 54e congr\u00e8s de l'ASH American Society of Hematology, 8-11 d\u00e9cembre 2012, Atlanta\";s:8:\"\u0000*\u0000title\";s:65:\"Nouveaux agents et nouvelles classes th\u00e9rapeutiques (Ph I-Ph II)\";s:8:\"\u0000*\u0000place\";s:10:\"Courbevoie\";s:6:\"\u0000*\u0000pub\";s:6:\"DaTeBe\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:65:\"Nouveaux agents et nouvelles classes th\u00e9rapeutiques (Ph I-Ph II)\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Correspondances en onco-h\u00e9matologie\";s:9:\"\u0000*\u0000stitle\";s:0:\"\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:1:\"8\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"11\";s:8:\"\u0000*\u0000epage\";s:2:\"15\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1954-4820\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"HEBRAUD\";s:10:\"\u0000*\u0000aufirst\";s:1:\"B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:4:\"SUP2\";s:9:\"\u0000*\u0000btitle\";s:132:\"Compte-rendu sur le my\u00e9lome multiple d'apr\u00e8s le 54e congr\u00e8s de l'ASH American Society of Hematology, 8-11 d\u00e9cembre 2012, Atlanta\";s:8:\"\u0000*\u0000title\";s:65:\"Nouveaux agents et nouvelles classes th\u00e9rapeutiques (Ph I-Ph II)\";s:8:\"\u0000*\u0000place\";s:10:\"Courbevoie\";s:6:\"\u0000*\u0000pub\";s:6:\"DaTeBe\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
